Theoretically, these drugs may play a certain role in the prevention and treatment of cerebrovascular diseases, but the feasibility of the scheme needs to be verified by evidence-based medicine. At present, the conventional infusion prevention methods have not been scientifically, strictly and clinically verified on a large scale, and infusion increases the chance of infection. Infusion reaction Infusion is directly administered intravenously.
This increases the chances of infection and transfusion reactions, such as fever, pulmonary edema, phlebitis and air embolism. During transfusion, foreign bodies entering blood vessels will cause blood infection and vascular endothelial damage, leading to lipid deposition and atherosclerosis, and form new embolism over time.
Blood transfusion is not suitable as a secondary preventive measure. The secondary prevention of cerebrovascular diseases mostly requires long-term or even lifelong medication. Blood transfusion is only a temporary way of administration, so it is not suitable as a secondary preventive measure. Moreover, infusion actually takes effect very quickly on acute cerebral infarction, and hospitals often use intravenous infusion for treatment.
The drugs used are usually some antiplatelet preparations and traditional Chinese medicine injections, and some patients benefit from them. Patients have also gained some experience in previous treatments, that is, infusion can often partially alleviate clinical symptoms and get quick results. Therefore, most patients will take the initiative to choose intravenous infusion when conducting secondary prevention.